Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tsakos Energy Navigation

16.88
+0.48002.93%
Post-market: 16.880.00000.00%16:44 EDT
Volume:291.08K
Turnover:4.89M
Market Cap:508.55M
PE:3.36
High:17.04
Open:16.36
Low:16.22
Close:16.40
Loading ...

TEN Holdings' Subsidiary Delivers Scalable Solutions with Zero Downtime for a Big 4 Consulting Firm's Global Broadcasts

PR Newswire
·
17 Apr

TEN Ltd. Announces the Filing of Form 20-F With the SEC

GlobeNewswire
·
16 Apr

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a Treatment for Patients with Previously Untreated Microsatellite Instability-High or Mismatch Repair Deficient Unresectable or Metastatic Colorectal Cancer1

Business Wire
·
09 Apr

Press Release: TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares

Dow Jones
·
05 Apr

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Business Wire
·
31 Mar

Reported Friday, TEN Holdings 2024 EPS $(0.12) Down From $(0.07) YoY, Revenue $3.5M Down From $3.7M YoY

Benzinga
·
31 Mar

Analysts Conflicted on These Energy Names: Tsakos Energy Navigation (TEN) and PBF Energy (PBF)

TIPRANKS
·
30 Mar

Tsakos Energy Navigation Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
30 Mar

Tsakos Energy Navigation’s Optimistic Earnings Call Highlights

TIPRANKS
·
29 Mar

Press Release: TEN Holdings, Inc. Reports Full Year 2024 Financial Results

Dow Jones
·
29 Mar

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

Business Wire
·
28 Mar

What's Going On With Tsakos Energy Navigation Stock Today?

Benzinga
·
28 Mar

Tsakos Energy Navigation Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

TEN, Ltd. reports Q4 EPS 42c vs. 85c last year

TIPRANKS
·
27 Mar

Scinai signs an option agreement to acquire rare disease company Pincell and its novel antibody for treating Severe Dermatological Conditions

PR Newswire
·
27 Mar

Tsakos Energy Navigation Q4 2024 GAAP EPS $0.42 Beats $0.37 Estimate, Sales $188.26M Beat $166.22M Estimate

Benzinga
·
27 Mar

BRIEF-Ten Ltd. Reports Profits For The 12 Months And Fourth Quarter Ended December 31, 2024 And Announces Common Share Dividend

Reuters
·
27 Mar

Tsakos Energy Navigation Ltd: Qtrly EPS $0.42

THOMSON REUTERS
·
27 Mar

Ten Ltd. Reports Profits for the 12 Months and Fourth Quarter Ended December 31, 2024 and Announces Common Share Dividend

THOMSON REUTERS
·
27 Mar

TEN Ltd. Reports Profits for the 12 Months and Fourth Quarter Ended December 31, 2024 and Announces Common Share Dividend

GlobeNewswire
·
27 Mar